Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-20-016183

Options or other derivatives

  • Director acquired 26,503 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Miller-Rich Nancy Director 2020-06-09 Grant or award · Stock Option (Right to Buy) +26,503 26,503 D
Loading xslF345X03/doc4.xml…